A novel peptide therapeutic targeting PD1 immune checkpoint with equipotent antagonism of both ligands and a potential for better management of immune-related adverse events

Detalles Bibliográficos
Autores principales: Sasikumar, Pottayil, Shrimali, Rajeev, Adurthi, Sreenivas, Ramachandra, Raghuveer, Satyam, Leena, Dhudashiya, Amit, Samiulla, Dodheri, Sunilkumar, K B, Ramachandra, Murali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991264/
http://dx.doi.org/10.1186/2051-1426-1-S1-O24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991264/
http://dx.doi.org/10.1186/2051-1426-1-S1-O24

Ejemplares similares